Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.08 is 53% below its 2-year average of 4.43, near the low end of its 2-year range (2.08–11.62).
As of the fiscal period ended Tuesday, June 30, 2026. 6.92% below its 12-month average of 2.24.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.08.
QUICK RATIO (ACID-TEST)
2.08
QUICK RATIO (ACID-TEST) AVG TTM
2.24
QUICK RATIO (ACID-TEST) AVG 3Y
N/A
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-6.92%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.19
median of 741 covered companies
CURRENT VS SECTOR MEDIAN
-34.64%
vs the sector median at left
Filana Therapeutics, Inc.
Market Cap
$40.67M
Quick Ratio (Acid-Test)
2.08
TTM Avg
2.24
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$40.28M
Quick Ratio (Acid-Test)
4.50
TTM Avg
7.06
3Y Avg
6.43
5Y Avg
6.01
Market Cap
$38.88M
Quick Ratio (Acid-Test)
0.98
TTM Avg
0.82
3Y Avg
0.91
5Y Avg
1.06
Market Cap
$42.61M
Quick Ratio (Acid-Test)
1.56
TTM Avg
1.00
3Y Avg
1.05
5Y Avg
1.35
Market Cap
$38.35M
Quick Ratio (Acid-Test)
48.81
TTM Avg
25.84
3Y Avg
15.89
5Y Avg
15.79
Market Cap
$43.14M
Quick Ratio (Acid-Test)
0.76
TTM Avg
2.59
3Y Avg
1.53
5Y Avg
1.04
Market Cap
$43.97M
Quick Ratio (Acid-Test)
2.59
TTM Avg
4.64
3Y Avg
4.51
5Y Avg
11.47
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Filana Therapeutics, Inc. (FLNA) | $40.67M | 2.08 | 2.24 | N/A | N/A |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.28M | 4.50 | 7.06 | 6.43 | 6.01 |
| Nephros, Inc. (NEPH)vs › | $39.96M | 2.71 | 3.27 | 3.24 | 4.04 |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.88M | 0.98 | 0.82 | 0.91 | 1.06 |
| Precipio, Inc. (PRPO)vs › | $42.61M | 1.56 | 1.00 | 1.05 | 1.35 |
| Incannex Healthcare Limited (IXHL)vs › | $38.35M | 48.81 | 25.84 | 15.89 | 15.79 |
| BioStem Technologies, Inc. (BSEM)vs › | $43.14M | 0.76 | 2.59 | 1.53 | 1.04 |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.97M | 2.59 | 4.64 | 4.51 | 11.47 |
| CVRx, Inc. (CVRX)vs › | $44.05M | 6.87 | 8.83 | 11.21 | 12.90 |
| DarioHealth Corp. (DRIO)vs › | $44.35M | 1.92 | 2.71 | 2.94 | 3.18 |
Quick Ratio
2.08
Excludes inventory
Current Ratio
2.08
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.08 |
| 2026-03-31 | 2.19 |
| 2025-12-31 | 2.23 |
| 2025-09-30 | 2.27 |
| 2025-06-30 | 2.43 |
| 2025-03-31 | 9.08 |
| 2024-12-31 | 11.62 |
| 2024-09-30 | 3.55 |
